EZH2 and pulmonary arterial hypertension: To further dissect the EZH2 downstream signaling pathways in PAH-PASMCs, an LC-MS/MS proteomics approach was applied to appreciate global protein abundance changes in PAH-PASMCs treated or not with siEZH2.